AR and posterior cortical atrophy: About 80~90% of PCa remains sensitive to androgen at the initial diagnosis, and androgen deprivation therapy (ADT), which aims to reduce serum androgen and inhibit the function of androgen receptors, is currently administered as primary systemic standard treatment for regional or advanced PCa [4, 5].